Matricelf

Matricelf Stock-Based Compensation

The Stock-Based Compensation (SBC) of Matricelf (MTLF.TA) as of Oct 22, 2026 is 3.89 M ILS. In the previous year, Stock-Based Compensation (SBC) was 3.78 M ILS — a change of 2.75% (higher).

Stock-Based Compensation

3.89 MILS

YoY

2.75%

Last updated:

Stock-Based Compensation (SBC) of Matricelf is 2024 3.89 M ILS. Stock-Based Compensation (SBC) of Matricelf was 2023 3.78 M ILS. It decreases by 2.75% higher compared to the previous year.

The Matricelf Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2021
9.01 M ILS
Jan 1, 2023
3.78 M ILS
Jan 1, 2024
3.89 M ILS
The Matricelf Stock-Based Compensation history
YEARStock-Based CompensationYoY
3.89 MILS+2.75%
3.78 MILS-58.03%
9.01 MILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Matricelf Stock analysis

What does Matricelf do? Matricelf Ltd. is a biotechnology company that engages in research and development of a platform for autologous matrix and cell implants in the field of regenerative medicine and tissue engineering. The firm develops a platform for autologous 3D printing of neutral human matrix, cells, tissues and organs implants. The implants are manufactured using cellular components originated from the patients themselves, to reduce potential immune response. The firm focuses on the treatment of spinal cord injury (SCI), but is also involved in developing treatment for additional medical conditions, including: Myocardial Infarction (MI), Parkinson’s disease and Age-related Macular Degeneration (AMD). Matricelf Ltd is a spin-out company from Tel Aviv University. Matricelf is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Matricelf stock

Stock-Based Compensation (SBC) of Matricelf is 3.89 M ILS in 2024.

Stock-Based Compensation (SBC) of Matricelf changed from 3.78 M ILS to 3.89 M ILS, representing a 2.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Matricelf since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Matricelf historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Matricelf

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Matricelf